Clinical Trial Update: Combination Therapy for Chronic Hepatitis C Infection [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a combination therapy for chronic hepatitis C infection has completed; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Hepatitis C, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2017-04-11